These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 33487183)
1. An audit of UK audiological practice in specialist paediatric oncology centres regarding hearing assessment of children at risk of ototoxicity due to chemotherapy. Brown ECM; Caimino C; Benton CL; Baguley DM J Laryngol Otol; 2021 Jan; 135(1):14-20. PubMed ID: 33487183 [TBL] [Abstract][Full Text] [Related]
2. Comments on published article 'An audit of UK audiological practice in specialist paediatric oncology centres regarding hearing assessment of children at risk of ototoxicity due to chemotherapy' by Brown Dasgupta S; Pizer B; Ratnayake S; Hayden J; O'Hare M J Laryngol Otol; 2021 Apr; 135(4):373-374. PubMed ID: 33726873 [No Abstract] [Full Text] [Related]
3. Current practice of ototoxicity management across the United Kingdom (UK). Maru D; Malky GA Int J Audiol; 2018 Sep; 57(sup4):S76-S88. PubMed ID: 29676584 [TBL] [Abstract][Full Text] [Related]
4. Applications of the Grading Scales for the Detection of Ototoxicity in Children after Treatment of Neuroblastoma and Extracranial Germinal Tumor. Polski B; Sosnowska-Sienkiewicz P; Szydłowski J; Januszkiewicz-Lewandowska D Audiol Neurootol; 2023; 28(1):32-42. PubMed ID: 36191558 [TBL] [Abstract][Full Text] [Related]
5. Ototoxicity monitoring through the eyes of the treating physician: Perspectives from pulmonology and medical oncology. Garinis AC; Cornell A; Allada G; Fennelly KP; Maggiore RJ; Konrad-Martin D Int J Audiol; 2018 Sep; 57(sup4):S19-S24. PubMed ID: 28978238 [TBL] [Abstract][Full Text] [Related]
6. Audiological ototoxicity monitoring guidelines: a review of current evidence and appraisal of quality using the AGREE II tool. Lester GM; Wilson WJ; Timmer BHB; Ladwa RM Int J Audiol; 2024 Oct; 63(10):747-752. PubMed ID: 38062855 [TBL] [Abstract][Full Text] [Related]
7. Ototoxicity monitoring in South African cancer facilities: A national survey. Ehlert K; Heinze B; Swanepoel W S Afr J Commun Disord; 2022 Jan; 69(1):e1-e10. PubMed ID: 35144440 [TBL] [Abstract][Full Text] [Related]
8. Long-term auditory follow-up in the management of pediatric platinum-induced ototoxicity. Fetoni AR; Brigato F; De Corso E; Lucidi D; Sergi B; Scarano E; Galli J; Ruggiero A Eur Arch Otorhinolaryngol; 2022 Oct; 279(10):4677-4686. PubMed ID: 35024956 [TBL] [Abstract][Full Text] [Related]
9. Epidural analgesia in children. A survey of current opinions and practices amongst UK paediatric anaesthetists. Williams DG; Howard RF Paediatr Anaesth; 2003 Nov; 13(9):769-76. PubMed ID: 14617117 [TBL] [Abstract][Full Text] [Related]
10. Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa. Paken J; Govender CD; Pillay M; Ayele BT; Sewram V BMC Cancer; 2021 Jul; 21(1):822. PubMed ID: 34271863 [TBL] [Abstract][Full Text] [Related]
11. Insight into the current practice of ototoxicity monitoring during cisplatin therapy. Santucci NM; Garber B; Ivory R; Kuhn MA; Stephen M; Aizenberg D J Otolaryngol Head Neck Surg; 2021 Mar; 50(1):19. PubMed ID: 33766142 [TBL] [Abstract][Full Text] [Related]
12. Ototoxicity monitoring in children treated with platinum chemotherapy. Brooks B; Knight K Int J Audiol; 2018 Sep; 57(sup4):S34-S40. PubMed ID: 28737048 [TBL] [Abstract][Full Text] [Related]
13. Surveillance for ototoxicity in platinum-based chemotherapy using mobile health audiometry with extended high frequencies. Ehlert K; Heinze B; Graham MA; Swanepoel D J Laryngol Otol; 2023 Jan; 137(1):61-67. PubMed ID: 35611593 [TBL] [Abstract][Full Text] [Related]
14. Ototoxicity in childhood: Recommendations of the CODEPEH (Commission for the Early Detection of Childhood Hearing Loss) for prevention and early diagnosis. Núñez-Batalla F; Jáudenes-Casaubón C; Sequí-Canet JM; Vivanco-Allende A; Zubicaray-Ugarteche J Acta Otorrinolaringol Esp (Engl Ed); 2022; 73(4):255-265. PubMed ID: 35872300 [TBL] [Abstract][Full Text] [Related]
15. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156 [TBL] [Abstract][Full Text] [Related]
16. Research protocol: Cisplatin-associated ototoxicity amongst patients receiving cancer chemotherapy and the feasibility of an audiological monitoring program. Paken J; Govender CD; Sewram V BMC Womens Health; 2017 Dec; 17(1):129. PubMed ID: 29228931 [TBL] [Abstract][Full Text] [Related]
17. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. van As JW; van den Berg H; van Dalen EC Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737 [TBL] [Abstract][Full Text] [Related]
18. Looking beyond the audiogram in ototoxicity associated with platinum-based chemotherapy. Baguley DM; Prayuenyong P Cancer Chemother Pharmacol; 2020 Feb; 85(2):245-250. PubMed ID: 31865419 [TBL] [Abstract][Full Text] [Related]
19. The current state of ototoxicity monitoring in New Zealand. Steffens L; Venter K; O'Beirne GA; Kelly-Campbell R; Gibbs D; Bird P N Z Med J; 2014 Jul; 127(1398):84-97. PubMed ID: 25146864 [TBL] [Abstract][Full Text] [Related]
20. Ototoxicity in cancer survivors: Experience and proposal of a surveillance protocol. Sánchez-Canteli M; Núñez-Batalla F; Martínez-González P; de Lucio-Delgado A; Antonio Villegas-Rubio J; Gómez-Martínez JR; Luis Llorente-Pendás J An Pediatr (Engl Ed); 2021 Nov; 95(5):290-297. PubMed ID: 34702687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]